This week hosts Mark Masselli and Margaret Flinter speak with renowned virus expert Dr. William Haseltine who has ‘grave concerns’ about Merck’s oral COVID drug Malnupiravir, which recently won narrow approval from the FDA advisory panel. He says the drug unleashes ‘dangerous’ mutations that could evolve the virus beyond control. He’s also urging extreme caution as the highly infectious omicron variant is sweeping across the US, saying it could be as deadly as the delta variant and that boosters may offer only limited protection of 3 months. Dr Haseltine, who developed the Anthrax vaccine and is President of ACCESS Health International, says public health protocols of masking, rapid testing and social distancing should be put back in place during this next surge.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast November 21, 2024 TV ads focused on health care issues — including transgender…
Originally broadcast November 14, 2024 There are 27 million Americans who have medical debt on…
Originally broadcast November 6, 2024The current life expectancy at birth is 74.8 years for males…
Originally broadcast April 9, 2024 The upcoming presidential election is stressing out 69% of American…
Originally broadcast October 17, 2024 For nearly the first decade of the National Institutes of…
Originally broadcast October 10, 2024 The countdown is on to election day with health care…